4893 items matching your search terms.

Chronic health conditions and poverty: a cross-sectional study using a multidimensional poverty measure

Callander, E.J. Schofield, D.J. Shrestha, R.N.
BMJ OPEN, 2013     DOI:10.1136/bmjopen-2013-003397

A KT intervention including the evidence alert system to improve clinician's evidence-based practice behavior-a cluster randomized controlled trial

Campbell, L. Novak, I. McIntyre, S. Lord, S.
IMPLEMENTATION SCIENCE, 2013     DOI:10.1186/1748-5908-8-132

Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?

Carberry, A.E. Raynes-Greenow, C.H. Turner, R.M. Askie, L.M. Jeffery, H.E.
PEDIATRIC RESEARCH, 2013     DOI:10.1038/pr.2013.156

SNAC trial decision making/cost effectiveness

Carter, H

A microsimulation model of the economic burden of premature mortality in Australia

Carter, H Schofield, D Shrestha, R

The cost effectiveness of bevacizumab when added to capecitabine , with or without mitomycin-C, in first line treatment of metastatic colorectal cancer: results from the Australasian phase III MAX study

Carter, H Zannino, D Simes, J Schofield, D Howard, K Zalcberg, J Price, T Tebbutt, N

Impact of baseline and nadir neutrophil index in non-small cell lung cancer and ovarian cancer patients: Assessment of chemotherapy for resolution of unfavourable neutrophilia

Carus, A. Gurney, H. Gebski, V. Harnett, P. Hui, R. Kefford, R. Wilcken, N. Ladekarl, M. von der Maase, H. Donskov, F.
JOURNAL OF TRANSLATIONAL MEDICINE, 2013     DOI:10.1186/1479-5876-11-189

Imatinib failure-free survival in patients with localized gastrointestinal stromal tumors treated with adjuvant imatinib: the EORTC/AGITG/FSG/GEIS/ISG randomized controlled phase III trial

Casali, PG LeCesne, A Valasco, AP Kotasek, D Rutkowski, P Hohenberger, P Fumagalli, E Judson, IR Italiano, A Broto, JM Gronchi, A Dei Tos, AP Marreaud, S Van Der Graaf, WTA Zalcberg, JR Litière, S Blay, JY EORTC Soft Tissue and Bone Sarcoma Group (EORTC STBSG), French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), Grupo Español de Investigación en Sarcomas (GEIS), Australasian Gastro-Intestinal Trials Group (AGITG),

Long-term analysis of a phase III randomized, intergroup, international trial assessing the clinical activity of imatinib at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors

Casali, PG Zalcberg, J Le Cesne, A Reichardt, P Blay, JY Lindner, L Judson, I Fumagalli, E Hogendoorn, P Natukunda, A Marreaud, S Litiere, S van Der Graaf, WTA

A randomised controlled trial of a mindfulness intervention for men with advanced prostate cancer

Chambers, S. K. Smith, D. P. Berry, M. Lepore, S. J. Foley, E. Clutton, S. McDowall, R. Occhipinti, S. Frydenberg, M. Gardiner, R. A.

Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

Chan, K. H. O'Connell, R. L. Sullivan, D. R. Hoffmann, L. S. Rajamani, K. Whiting, M. Donoghoe, M. W. Vanhala, M. Hamer, A. Yu, B. Stocker, R. Ng, M. K. Keech, A. C. on behalf of the FIELD study investigators,
DIABETOLOGIA, 2013     DOI:10.1007/s00125-012-2818-4

Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

Chan, K. H. O'Connell, R. L. Sullivan, D. R. Hoffmann, L. S. Rajamani, K. Whiting, M. Donoghoe, M. W. Vanhala, M. Hamer, A. Yu, B. Stocker, R. Ng, M. K. C. Keech, A. C.
DIABETOLOGIA, 2013     DOI:10.1007/s00125-012-2818-4

The IMPaCT trial: Individualised Molecular Pancreatic Cancer Therapy. A pilot, randomised, open label phase II trial assessing first line treatment with gemcitabine or personalized treatment based on tumour molecular signature in patients with metastatic pancreatic cancer

Chantrill, L Johns, A Nagrial, A Chin, V Chou, A Pinese, M Mead, S Gebski, V Sjoquist, K Lee, C Yip, S Miller, D Sebastian, L Asghari, R Harvey, S Pavlakis, N Mukhedkar, S Grimison, P Miller, D Pearson, J Waddell, N Grimmond, S Simes, J Biankin, A

Therapeutic effects of PPARα agonists on diabetic retinopathy in type 1 diabetes models

Chen, Y. Hu, Y. Lin, M. Jenkins, A.J. Keech, A.C. Mott, R. Lyons, T.J. Ma, J.X.
DIABETES, 2013     DOI:10.2337/db11-0413.

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials [abstract]

Cholesterol Treatment Trialist (CTT) Collaborators,